showed a trendP = 0.072
In comparison between adherent and nonadherent patients, adherent patients showed a trend toward improved primary efficacy (HR: 0.62; 95% CI: 0.36-1.04; P = 0.072) but comparable safety (HR: 1.19; 95% CI: 0.44-3.25; P = 0.732) outcomes.